investorscraft@gmail.com

Intrinsic ValueVitalhub Corp. (VHI.TO)

Previous Close$8.43
Intrinsic Value
Upside potential
Previous Close
$8.43

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Vitalhub Corp. operates in the healthcare information services sector, delivering specialized technology solutions to health and human service providers across multiple geographies, including Canada, the U.S., the U.K., and Australia. The company’s core offerings encompass electronic healthcare records, case management, care coordination, and patient flow optimization tools, which enhance operational efficiency for healthcare institutions. By focusing on interoperability and mobile-enabled solutions, Vitalhub addresses critical gaps in healthcare IT infrastructure, positioning itself as a key enabler of digital transformation in the sector. Its diversified client base and recurring revenue model, driven by software subscriptions and maintenance services, provide stability amid evolving regulatory and technological demands. The company competes in a fragmented but growing market, leveraging its niche expertise in workflow optimization and data integration to differentiate from larger, generalized healthcare IT providers.

Revenue Profitability And Efficiency

Vitalhub reported revenue of CAD 68.6 million in FY 2024, with net income of CAD 3.0 million, reflecting a net margin of approximately 4.4%. Operating cash flow stood at CAD 15.1 million, underscoring efficient cash conversion. Capital expenditures were modest at CAD -0.9 million, indicating a capital-light model focused on scalable software solutions rather than heavy infrastructure investments.

Earnings Power And Capital Efficiency

The company’s diluted EPS of CAD 0.0589 demonstrates modest but positive earnings power. With minimal debt (CAD 0.6 million) and robust cash reserves (CAD 56.6 million), Vitalhub maintains strong capital efficiency, allowing flexibility for organic growth or strategic acquisitions without overleveraging its balance sheet.

Balance Sheet And Financial Health

Vitalhub’s balance sheet is notably healthy, with cash and equivalents exceeding total debt by a wide margin. The negligible debt-to-equity ratio and high liquidity position the company to navigate macroeconomic uncertainties while funding innovation or market expansion initiatives.

Growth Trends And Dividend Policy

Growth is primarily organic, supported by cross-selling and geographic expansion. The company does not pay dividends, reinvesting cash flows into product development and potential M&A to capture market share in the high-growth healthcare IT space.

Valuation And Market Expectations

At a market cap of CAD 548.6 million, Vitalhub trades at a premium to peers, reflecting investor confidence in its niche positioning and recurring revenue model. The beta of 0.791 suggests lower volatility relative to the broader market, aligning with its stable healthcare clientele.

Strategic Advantages And Outlook

Vitalhub’s strategic focus on interoperable, workflow-enhancing software aligns with global healthcare digitization trends. Its strong balance sheet and recurring revenue base provide resilience, while international expansion opportunities offer upside. Execution risks include competition from larger IT vendors and regulatory complexities in new markets.

Sources

Company filings, TSX disclosures

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount